ArticleFrontiers in endocrinology2025
The impact of diabetes and social, biologic and behavioral determinants of health on liver cancer risk.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver cancer has seen a concerning rise in incidence, currently ranked as the sixth most prevalent cancer. Diabetes, along with indices of social, biological, and behavioral determinants of health, was linked to the risk of liver cancer. Aim: We aim to determine the effect of diabetes and selected indices of determinants of health on liver cancer. Methods: Our quantitative study is based on a sample of 239,006 US participants adopted from the BRFSS-2022 data. Our results are summarized using frequency distributions and weighted percentages. Weighted logistic regressions were employed to determine the associations with liver cancer. Results: In this sample population, 73 individuals experienced liver cancer, 12.17% (n=33,776) had diabetes, with a four-fold increase in the odds of liver cancer for individuals with diabetes (OR: 4.27, CI: 1.73-10.57). Employment status, educational level, urban/rural living, smoking status were determinants of health associated with liver cancer as well. Our subgroup analysis focusing exclusively on those diagnosed with liver cancer following their diabetes diagnosis confirmed diabetes as risk factor for liver cancer (OR: 5.44, 95%CI: 1.58-18.70), along with marital status and other determinants of health. Conclusion: Effective diabetes management and addressing key health determinants are crucial for reducing liver cancer risk and improving prevention and treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.